India proposes anti-dumping duties on Chinese pharma raw materials

admin November 9, 2021
Updated 2021/11/09 at 10:16 AM

To protect local players against low-cost imports, the Commerce Ministry has proposed imposing anti-dumping duties on a pharma raw material from China, Ceftriaxone Sodium Sterile.

After completing its investigation, the Directorate General of Trade Remedies (DGTR) proposed the tax after finding that API (active pharmaceutical ingredient) from China was shipped at dropped prices into India, causing damage to the local sector.

In a notice, the directorate said, “The authority proposes the application of the anti-dumping tax on the importation of subject products…”

Ceftriaxone Sodium Sterile is an API that is used in the formulation of drugs to treat infections of the lower respiratory tract, skin and skin structures, and surgical prophylaxis.

The investigation was launched when Nectar Life Sciences and Sterile India filed a complaint regarding the chemical’s disposal.

The suggested duty is $ 12.91 per kilogram. The ultimate decision to impose duty is made by the Finance Ministry.

In a separate announcement, the DGTR said that it has launched a sunset review investigation on the necessity for sustained anti-dumping charges on Chinese aluminium foil.

The World Trade Organization (WTO) allows for the application of anti-dumping tariffs.

The tax is intended to ensure fair trade practises and to level the playing field for local producers and exporters in comparison to international producers and exporters.


Source: The Hindu

Share this Article
Leave a comment

Leave a Reply

Your email address will not be published.